This pattern of expression supports the hypothesis that Survivin plays a functional role in normal ependymal growth and/or neural stem cell differentiation, and that abnormally low levels of expression of the nuclear form of this protein may be a marker of disease aggression and/or morphologic grade in ependymal and CP tumours. The gene discussed is BIRC5; the disease is neoplasm.